Articles

Want to know your risk of chronic disease as you age? Don’t waste money trying to find out.

What you should know before you try genetic testing

B. Riley’s stock rallies 26% after founder offers to buy rest of troubled bank for $7 a share

B. Riley Financial Inc.’s stock rallied 26% on Friday after Bryant R. Riley, the founder, chairman, co-chief executive and largest shareholder of the troubled investment bank, made an offer to buy the stock he doesn’t already own for $7 a share.

Billions of Social Security numbers may have been exposed. Here’s how to protect yourself against theft and scams. 

Shore up your account protections and file a report if you suspect you’re a victim.

Consumer sentiment picks up for first time in five months in August

‘Consumers vote with their wallets, and household spending overall is still in solid shape,’ one economist noted.

British economist named as new member of Bank of England’s rates committee

Columbia University professor Alan Taylor will replace Jonathan Haskel as a member of the Bank of England’s monetary policy committee.

Can you recommend a financial planner who can look over my investments?  

Here’s an answer to what is probably the most-asked question in the financial planning world.

Alphabet’s stock is set to break this bearish record as investor concerns mount

Alphabet’s stock needs to rally 1.5% Friday to be up on the week and not set a new record weekly losing streak.

Retailers have pulled back on raising prices. More are now lowering them.

Since February 2023, analysts at D.A. Davidson have been tracking prices online for a representative set of products across their retail coverage.

New-home construction plunges to lowest level since May 2020 

Construction on new U.S. homes fell 6.8% in July, the Commerce Department said Friday.

Why investors have suddenly halted the long-running switch to index funds

The long-running trend of investors moving money out of active equity funds and into passive funds is on pause as individual stocks start trading less in sync with other equities.

Oil prices turn negative on week as demand fears outweigh Middle East war jitters

Oil futures were lower Friday morning, giving up a weekly gain as worries about demand proved persistent, overshadowing fears of a retaliatory strike by Iran on Israel.

Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectives

Pfizer and BioNTech said Friday that a Phase 3 trial of their COVID-19-and-influenza combination vaccine candidate met one of its two objectives.
1 911 912 913 914 915 2,364